Para-boronophenylalanine (BPA) agent, specific for the L-type amino acid transporter 1 (LAT1) expressed in tumors, can selectively uptake the boron compounded into cancer, while the lower uptake into normal tissues is expected [2, 3]. The gene discussed is SLC7A5; the disease is cancer.